These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9359947)

  • 21. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Streptococcus pyogenes resistance to erythromycin in Slovakia: is there a correlation with consumption?
    Krcmery V; Foltan V; Langsadl L; Liskov A; Babela R
    Scand J Infect Dis; 2002; 34(5):400. PubMed ID: 12069033
    [No Abstract]   [Full Text] [Related]  

  • 23. Lowering the rate of antibiotic resistance.
    Rohner CD; Force RW
    J Fam Pract; 1997 Nov; 45(5):374. PubMed ID: 9374954
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
    Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
    Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD.
    Avanzini C; Bosio K; Volpe G; Dotti G; Savoia D
    Microb Drug Resist; 2000; 6(4):289-95. PubMed ID: 11272257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrolide resistance in beta-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea.
    Kim HY; Uh Y
    Yonsei Med J; 2004 Aug; 45(4):591-7. PubMed ID: 15344198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A regionwide intervention to promote appropriate antibiotic use in children reversed trends in erythromycin resistance to Streptococcus pyogenes.
    Gagliotti C; Buttazzi R; Di Mario S; Morsillo F; Moro ML
    Acta Paediatr; 2015 Sep; 104(9):e422-4. PubMed ID: 26058421
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
    Gagliotti C; Nobilio L; Milandri M; Moro ML;
    Clin Infect Dis; 2006 Apr; 42(8):1153-6. PubMed ID: 16575736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi drug resistance in group A hemolytic streptococci in Japan from 1972 to 1977.
    Yamada T; Kosakai N
    Jpn Circ J; 1980 Oct; 44(10):801-3. PubMed ID: 7001083
    [No Abstract]   [Full Text] [Related]  

  • 30. Streptococcus pyogenes: resistant, tolerant, neither or both?
    Mortensen JE; McDowell T
    Adv Exp Med Biol; 1995; 390():109-17. PubMed ID: 8718606
    [No Abstract]   [Full Text] [Related]  

  • 31. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
    Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
    Hsueh PR; Shyr JM; Wu JJ
    Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Group A streptococci. Erythromycin resistance and penicillin tolerance.
    Savoia D; Millesimo M; Dotti G; Milano F
    Adv Exp Med Biol; 1997; 418():447-9. PubMed ID: 9331690
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
    Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
    Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dirithromycin, a new antibiotic in the treatment of pharyngeal inflammation].
    Riazantsev SV; Kosenko VA; Vlasova VV; Volkova VV
    Vestn Otorinolaringol; 1995; (5):40-3. PubMed ID: 7502454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythromycin resistance in group A streptococci.
    Järvinen H; Nissinen A; Huovinen P
    Lancet; 1989 May; 1(8645):1022-3. PubMed ID: 2565500
    [No Abstract]   [Full Text] [Related]  

  • 37. Erythromycin-resistant group A streptococci.
    Linder JA; Stafford RS
    N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12192025
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
    Colakoglu S; Alacam R; Hascelik G
    Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
    Palavecino EL; Riedel I; Berrios X; Bajaksouzian S; Johnson D; Kaplan E; Jacobs MR
    Antimicrob Agents Chemother; 2001 Jan; 45(1):339-41. PubMed ID: 11120993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Update on antibiotic sensitive Streptococcus pyogenes in a pediatric population].
    Gené A; González-Cuevas A; Muñoz C; Luaces C; Latorre C
    Enferm Infecc Microbiol Clin; 2000 Mar; 18(3):144-5. PubMed ID: 10905020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.